Wire · founder news, decoded · opportunities
Rapid Medical announces US FDA clearance of Drivewire 35 alongside first stroke cases
◆ Published
22 July 2026
◆ Topic
opportunities
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 22 July 2026 · Fusion42 review
Rapid Medical received FDA clearance for Drivewire 35, a steerable 0.035-inch guidewire that allows physicians to navigate catheters through complex vessel anatomy during stroke intervention without crossing clots. First clinical cases show the device reduces procedure time and the need for additional nested devices.
This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.
◆ The Wire takeaway
If you make catheters, guidewires, or nested access devices for stroke intervention, Rapid Medical just proved that a single steerable wire can replace multi-device stacks. Your customers will want this—or your product becomes the thing they avoid buying.
◆ Related on Wire
- Gore Sees Opportunity in AI Screening, Venous Devices After Winning Ruptured AAA Label17 July 2026
- RBI Granted 'Fast Track' Designation by FDA, Validating Its Direc18 July 2026
- US FDA approves Abbott's longer-length Esprit for severe PAD16 July 2026
- FDA clears iHealthScreen's AI diabetic retinopathy screening software10 July 2026
- US FDA approves Sanofi's wearable injector form of blood cancer drug10 July 2026
- Blood-Brain Barrier Crossed: Denali's FDA Approval Unlocks Alzheimer's Pipeline12 July 2026
◆ Topics
Digital Health · neurovascular-intervention · stroke-treatment · medical-device-fda · guidewire-technology · intravascular-procedures